Zevra Therapeutics
在场
是其中之一......
Zevra Therapeutics 是一家在股票代码 ZVRA (US) 下上市的公司。
他们在：
高管
查看带有其 42 名主要高管的组织结构图
Zevra Therapeutics 搜索最多的简介
高管在Zevra Therapeutics变化
- Rahsaan Thompson已作为Chief Legal Officer, Secretary and Compliance Officer加入公司 (新闻发布的2024六月26号).
- Alison Peters已作为Chief People Officer加入公司 (新闻发布的2024六月26号).
创建提醒
跟踪 Zevra Therapeutics 的高管变动
药店
Zevra Therapeutics 拥有 1,837 家竞争者，其中包括 Pfizer (美国(美洲))、Johnson & Johnson (美国(美洲)) 和 Sanofi (法国)。
Popular M&A news in 药店
- Grace Therapeutics将在Oct 24, 2024将其名称改为Grace Therapeutics。 (公布2024十月27号).
- Orasis Pharmaceuticals 刚刚宣布为 78 筹款数百万美元。 (公布2024十月21号).
- Lundbeck has announced the acquisition of Longboard Pharmaceuticals (公布2024十月17号).
药店 行业的其他推荐联系人
消息
Zevra Therapeutics 的最新新闻稿
- KemPharm to Report Second Quarter 2022 Financial Results | KemPharm
- KemPharm to Present at the Canaccord Genuity 42nd Annual Growth Conference | KemPharm
- KemPharm Announces Research Affirming Serdexmethylphenidate’s Lower Potential for Abuse Featured in Peer-Reviewed Publication, Current Medical Research & Opinion | KemPharm
- Press Releases | KemPharm
- KemPharm Announces Strategic Acquisition of Arimoclomol from Orphazyme, Expanding its Rare CNS Diseases Pipeline | KemPharm
- KemPharm Reports First Quarter 2022 Financial Results and Corporate Updates | KemPharm
- Press Releases | KemPharm
- KemPharm to Present at Multiple Upcoming Investor Conferences | KemPharm
- KemPharm Announces Submission of Investigational New Drug Application for Phase 2 Trial of KP1077 in Idiopathic Hypersomnia (IH) | KemPharm
- KemPharm to Report First Quarter 2022 Financial Results | KemPharm
- View more press releases Close
通过电子邮件
